Free Trial
OTCMKTS:SUWN

Sunwin Stevia International (SUWN) Stock Price, News & Analysis

About Sunwin Stevia International Stock (OTCMKTS:SUWN)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
1,080 shs
Market Capitalization
$20,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It offers Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.

Remove Ads
Receive SUWN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sunwin Stevia International and its competitors with MarketBeat's FREE daily newsletter.

SUWN Stock News Headlines

10 Best Stevia Sweetners
Sunwin Stevia International Inc.
See More Headlines

SUWN Stock Analysis - Frequently Asked Questions

Shares of SUWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sunwin Stevia International investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Processa Pharmaceuticals (PCSA), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX) and Entasis Therapeutics (ETTX).

Company Calendar

Today
4/04/2025
Fiscal Year End
4/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:SUWN
Employees
240
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$35.26 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$20,000.00
Optionable
Not Optionable
Beta
-0.37
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:SUWN) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners